About hC Bioscience
hC Bioscience is a company based in Boston (United States) founded in 2021 by Leslie Williams. hC Bioscience has raised $24 million across 1 funding round from investors including Takeda Pharmaceuticals, Arch Venture Partners and 8VC. hC Bioscience offers products and services including tRNA Platform. hC Bioscience operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics and Revolution Medicines, among others.
- Headquarter Boston, United States
- Founders Leslie Williams
- SectorsHealthcare
- Phone•••• ••••
- Website hcbioscience.com
- Social LinkedIn
- Total Equity Funding$24M (USD)
in 1 rounds
- Latest Funding Round$24M (USD), Series B
Dec 2021
- InvestorsTakeda Pharmaceuticals
& 2 more
Products & Services of hC Bioscience
hC Bioscience offers a comprehensive portfolio of products and services, including tRNA Platform.
Corrects mutations by inserting amino acids to produce functional proteins.
Funding Insights of hC Bioscience
hC Bioscience has successfully raised a total of $24M through 1 strategic funding round. The most recent funding activity was a Series B round of $24 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $24M
- Total Rounds 1
- Last Round Series B — $24M
- First Round $24M
(Dec 2021)
- Investors Count 3
All 1 funding rounds of hC Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in hC Bioscience
hC Bioscience has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Takeda Pharmaceuticals, Arch Venture Partners and 8VC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in technology, life sciences, and related sectors. | – | 8vc.com | - | |
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Takeda Pharmaceuticals is engaged in developing innovative medicines globally. | 1781 | takeda.com | Tokyo, Japan |
Investor details for hC Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of hC Bioscience
16 people are tracked at hC Bioscience (3 in leadership, 11 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
Leslie Williams | Co-Founder & CEO | Leadership |
Leslie J. Williams | Co-Founder, Director, President & CEO | Leadership |
John Robblee | Senior Vice President, CMC | Leadership |
Brad Margus | Director | Board & advisors |
David Moskowitz | Director | Board & advisors |
Craig Mello | Chairman, Scientific Advisory Board | Board & advisors |
John Lueck | Scientific Advisor | Board & advisors |
Christopher Ahern | Scientific Advisor | Board & advisors |
Steven Gillis | Chairman, Board of Directors | Board & advisors |
John DiPersio | Scientific Advisor | Board & advisors |
Oladapo Yeku | Scientific Advisor | Board & advisors |
Sacha Mann | Director | Board & advisors |
John Bell | Scientific Advisor | Board & advisors |
Martin A. Maier | Scientific Advisor | Board & advisors |
Elena Paltrinieri | Senior Scientist Oncology Group | Team |
Anuj Gupta | Senior Scientist | Team |
Complete people profiles for hC Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of hC Bioscience
2 dated milestones of hC Bioscience, from founding to its latest funding, stage changes and deals.
- Founded hC Bioscience is founded.
- Funding First funding round of $24.0M.
Competitors of hC Bioscience
hC Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics and Revolution Medicines, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| jazzpharma.com | 2003 | Dublin, Ireland | $265M | 2,800 | Novel biopharmaceutical medicines are developed for unmet medical needs. | |
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | – | Therapeutics for genetic diseases are developed through targeted interventions. | |
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. | |
| revmed.com | 2014 | Redwood, United States | $326.29M | 181 | Cancer therapies are developed using selective pathway inhibitors. | |
| rhythmtx.com | 2010 | Boston, United States | $84M | 115 | Developer of peptide therapeutics for the treatment of rare genetic deficiencies | |
| blueprintmedicines.com | 2008 | Cambridge, United States | $115M | 201 | Selective kinase inhibitors are developed for genomically defined cancers. | |
| syndax.com | 2005 | Waltham, United States | $198.29M | 107 | Targeted therapies for cancer treatment are developed. | |
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. |
Detailed competitors of hC Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of hC Bioscience
Websites that share an audience with hC Bioscience (hcbioscience.com).
Websites whose visitors overlap most with hC Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cugene.com | 100% | 1.1K | #13,064,449 | View details | |
| oxeiabiopharma.com | 100% | 3.3K | #5,389,668 | View details | |
| marengotx.com | 98% | 3.3K | #5,030,761 | View details | |
| prometrika.com | 98% | – | #2,751,954 | View details | |
| vedantabio.com | 98% | 5.6K | #3,168,764 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for hC Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Hc Bioscience
Complete news archive for hC Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to hC Bioscience
10 companies that operate in the same segment as hC Bioscience (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about hC Bioscience
hC Bioscience was founded in 2021.
hC Bioscience is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Leslie Williams is the current CEO of hC Bioscience. They have also founded this company.
hC Bioscience is a funded company, having raised a total of $24M across 1 funding round to date. The company's 1st funding round was a Series B of $24M, raised on Dec 2021.
hC Bioscience was founded in 2021 and is based in Boston, United States. Focus is placed on biotechnology, specifically the development of RNA-based therapeutics targeting cancer and rare diseases. Protein editing is advanced beyond genome editing through proprietary tRNA-based technology, enabling direct proteome modification. Operations center on therapeutic applications in oncology and rare disease treatment within the biotech sector.
hC Bioscience's top competitors include Moderna, Jazz Pharmaceuticals and Spark Therapeutics.
hC Bioscience offers tRNA Platform.
hC Bioscience has 3 investors. Key investors include Takeda Pharmaceuticals, Arch Venture Partners, and 8VC.